Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Moderate-to-severe Atopic Dermatitis
Related studies linked through entity extraction aliases.
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3